Albireo Pharma
$44.15
11
-$0.1-0.23% Thursday 21:00
Statistics
Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
913.96M
P/E Ratio
-3.6
Dividend Yield
-
Dividend
-
Earnings
15MayExpected
Expected EPS
-1.6
Actual EPS
N/A
Financials
-83.86%Profit Margin
Unprofitable40.58MRevenue
-34.03MNet Income
People Also Follow
This list is based on the watchlists of people on Stock Events who follow ALBO. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Health Technology
Pharmaceuticals: Other
Manufacturing
Pharmaceutical Preparation Manufacturing
Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The company offers Bylvay for the treatment of progressive familial intrahepatic cholestasis, as well as in Phase III clinical trial for treating biliary atresia, alagille syndrome, and rare and life-threatening disorder to children; and Elobixibat for the treatment of chronic constipation and other functional diseases. It also engages in the developing of A3907, which is in Phase I clinical trial for the treatment of adult liver diseases; and A2342, a preclinical candidate to treat adult viral and liver diseases. The company has a license agreement with EA Pharma Co., Ltd. for the development and commercialization of elobixibat. Albireo Pharma, Inc. is headquartered in Boston, Massachusetts.
Show more...
CEO
Gary Gemignani
Employees
130
Country
US
ISIN
US01345P1066
WKN
000A2DF99
Listings
0 Comments
Share your thoughts
FAQ
What is Albireo Pharma stock price today?▼
The current price of ALBO is $44.15 USD — it has decreased by -0.23% in the past 24 hours. Watch Albireo Pharma stock price performance more closely on the chart.
What is Albireo Pharma stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Albireo Pharma stocks are traded under the ticker ALBO.
What is Albireo Pharma market cap?▼
Today Albireo Pharma has the market capitalization of 913.96M
What is Albireo Pharma revenue for the last year?▼
Albireo Pharma revenue for the last year amounts to 40.58M USD.
What is Albireo Pharma net income for the last year?▼
ALBO net income for the last year is -34.03M USD.
How many employees does Albireo Pharma have?▼
As of April 01, 2026, the company has 130 employees.
In which sector is Albireo Pharma located?▼
Albireo Pharma operates in the Manufacturing sector.
When did Albireo Pharma complete a stock split?▼
The last stock split for Albireo Pharma was on November 04, 2016 with a ratio of 1:30.
Where is Albireo Pharma headquartered?▼
Albireo Pharma is headquartered in Boston, US.